Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy

[1]  G. Nappi,et al.  Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model , 2007, The European journal of neuroscience.

[2]  C. Svendsen,et al.  Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro. , 2006, Experimental cell research.

[3]  E. Snyder,et al.  Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed , 2006, Experimental Neurology.

[4]  J. Kordower,et al.  Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates , 2006, Gene Therapy.

[5]  Mark Stacy,et al.  Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease , 2006, Annals of neurology.

[6]  C. Gaillard,et al.  Real-time quantitative PCR for the design of lentiviral vector analytical assays , 2005, Gene Therapy.

[7]  Nobuko Uchida,et al.  Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Svendsen,et al.  GDNF delivery using human neural progenitor cells in a rat model of ALS. , 2005, Human gene therapy.

[9]  I. Weissman,et al.  Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Jeffrey H Kordower,et al.  Human neural stem cell transplants improve motor function in a rat model of Huntington's disease , 2004, The Journal of comparative neurology.

[11]  D. Menon,et al.  Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. , 2004, The international journal of biochemistry & cell biology.

[12]  M. Wiznerowicz,et al.  Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference , 2003, Journal of Virology.

[13]  Jiang Li,et al.  Gene expression in human neural stem cells: effects of leukemia inhibitory factor , 2003, Journal of neurochemistry.

[14]  R. Morgan,et al.  Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. , 2003, Human gene therapy.

[15]  D. Brooks,et al.  Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease , 2003, Nature Medicine.

[16]  I. Weissman,et al.  Engraftment of sorted/expanded human central nervous system stem cells from fetal brain , 2002, Journal of neuroscience research.

[17]  C. Svendsen,et al.  Neurospheres modified to produce glial cell line‐derived neurotrophic factor increase the survival of transplanted dopamine neurons , 2002, Journal of neuroscience research.

[18]  J. Mallet,et al.  Long-Term Expression of β-Glucuronidase by Genetically Modified Human Neural Progenitor Cells Grafted into the Mouse Central Nervous System , 2002, Molecular and Cellular Neuroscience.

[19]  Patrick Aebischer,et al.  Isolation of Multipotent Neural Precursors Residing in the Cortex of the Adult Human Brain , 2001, Experimental Neurology.

[20]  D. Trono,et al.  The use of a recombinant lentiviral vector for ex vivo gene transfer into the rat CNS , 2000, Neuroreport.

[21]  E. Jauniaux,et al.  Human Neural Precursor Cells Express Low Levels of Telomerase in Vitro and Show Diminishing Cell Proliferation with Extensive Axonal Outgrowth following Transplantation , 2000, Experimental Neurology.

[22]  J. Ridet,et al.  Lentiviral Vectors as a Gene Delivery System in the Mouse Midbrain: Cellular and Behavioral Improvements in a 6-OHDA Model of Parkinson's Disease Using GDNF , 2000, Experimental Neurology.

[23]  M. Carpenter,et al.  In Vitro Expansion of a Multipotent Population of Human Neural Progenitor Cells , 1999, Experimental Neurology.

[24]  J. Mallet,et al.  A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors , 1999, Nature Biotechnology.

[25]  E. Parati,et al.  Isolation and Cloning of Multipotential Stem Cells from the Embryonic Human CNS and Establishment of Transplantable Human Neural Stem Cell Lines by Epigenetic Stimulation , 1999, Experimental Neurology.

[26]  Clive N Svendsen,et al.  A new method for the rapid and long term growth of human neural precursor cells , 1998, Journal of Neuroscience Methods.

[27]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[28]  S. Weiss,et al.  Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. , 1996, Developmental biology.

[29]  S. Dunnett,et al.  Survival and Differentiation of Rat and Human Epidermal Growth Factor-Responsive Precursor Cells Following Grafting into the Lesioned Adult Central Nervous System , 1996, Experimental Neurology.

[30]  E. Snyder,et al.  Gene therapy: can neural stem cells deliver? , 2006, Nature Reviews Neuroscience.

[31]  M. Wiznerowicz,et al.  A versatile tool for conditional gene expression and knockdown , 2006, Nature Methods.

[32]  L. Wahlberg,et al.  Proliferation, migration, and differentiation of human neural stem/progenitor cells after transplantation into a rat model of traumatic brain injury. , 2004, Journal of neurosurgery.

[33]  Y. Ye,et al.  Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors , 2002, Gene Therapy.

[34]  Y. Arsenijévic,et al.  Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. , 2000, Human gene therapy.